Lighthouse Investment Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.98M Buy
32,632
+26,844
+464% +$4.95M 0.21% 163
2025
Q4
$1.02M Sell
5,788
-22,212
-79% -$3.63M 0.03% 476
2025
Q3
$3.92M Buy
+28,000
New +$3.78M 0.12% 230
2024
Q3
Sell
-23,713
Closed -$5.5M 439
2024
Q2
$5.5M Buy
+23,713
New +$5.15M 0.22% 120
2024
Q1
Sell
-1,053
Closed -$272K 381
2023
Q4
$272K Buy
+1,053
New +$259K 0.01% 270

Other funds holding BIIB

Lighthouse Investment Partners's BIIB Position: Q1 2026 in Review

Lighthouse Investment Partners increased its Biogen (BIIB) stake by 464% in Q1 2026, buying an estimated $4.95M and bringing the position to 32,632 shares worth $5.98M. The position accounts for 0.21% of the portfolio, ranked #163.

Lighthouse Investment Partners first reported a position in BIIB in Q4 2023 and has held it in 5 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Lighthouse Investment Partners held 32,632 shares of Biogen worth $5.98M as of Q1 2026.
  • Lighthouse Investment Partners bought 26,844 Biogen shares in Q1 2026, an estimated $4.95M.
  • Biogen made up 0.21% of Lighthouse Investment Partners's portfolio in Q1 2026, its #163 holding.
  • Lighthouse Investment Partners first reported a position in Biogen in Q4 2023 and has held it in 5 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.